Tailoring modifications of polysaccharides in Mycobacterium tuberculosis
结核分枝杆菌多糖的剪裁修饰
基本信息
- 批准号:10685409
- 负责人:
- 金额:$ 63.76万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-17 至 2026-08-31
- 项目状态:未结题
- 来源:
- 关键词:AcademiaAffectAmino AcidsAnabolismAttentionBacillusBiochemicalBiochemistryBiocideBiologicalBiological MarkersC3HeB/FeJ MouseCOVID-19Carbohydrate ChemistryCarbohydratesCause of DeathCell WallCell surfaceCellsChargeColoradoDendritic CellsDevelopmentEnsureEnvironmentExclusionGalactosamineGenerationsGeneticGenus MycobacteriumGlycobiologyGram-Positive BacteriaGranulomaHost DefenseInfectionInfectious AgentKnock-outKnowledgeLaboratoriesLipopolysaccharidesLung infectionsMacrophageMediatingMembraneModelingModificationMusMycobacterium InfectionsMycobacterium tuberculosisNatural ImmunityNecrosisPathogenesisPathogenicityPathologyPatientsPersonsPhysiologicalPhysiological ProcessesPhysiologyPlayPolysaccharidesProkaryotic CellsResearch PersonnelResistanceRoleStressStructureSurface PropertiesTaiwanTeichoic AcidsTestingTherapeuticUniversitiesVirulenceWheatacyl groupadaptive immunityarabinogalactancell envelopedesignenvironmental stressorimmunopathologyinnovationinorganic phosphatelipoarabinomannanlipomannanmicroorganismmultidisciplinarymutantmycobacterialpathogenphysical propertyprophylacticresponsesugarthiosugartranscriptomics
项目摘要
Abstract
The covalent modification of prokaryotic cell envelope glycans, namely lipopolysaccharide (LPS) and
(lipo)teichoic acids, with discrete substituents such as sugars, amino acids, phosphates or acyl groups, is a
well-known strategy used by Gram-negative and Gram-positive bacteria to modulate their cell surface
properties, the way they interact with their environment, their resistance to biocides and host defenses, and
pathogenicity. Although evidence exists that Mycobacterium tuberculosis (Mtb) similarly decorates its major
cell envelope glycans, arabinogalactan (AG) and lipoarabinomannan (LAM), with various tailoring substituents,
little is known of their biological significance. The discovery by our laboratories of the biosynthetic machineries
responsible for the synthesis and transfer of these discrete motifs to AG and LAM, and the generation of the
first Mtb knock-out mutants deficient in their biosynthesis have opened the way to studies aimed at
understanding the function of these motifs in the physiology and immunopathogenesis of Mtb. We
hypothesize that Mtb has evolved to modify its cell-envelope glycans with a distinct array of
strategically placed substituents to promote its survival in the host environment. Accordingly, a
multidisciplinary team of investigators with complementary expertise in mycobacterial cell envelope genetics
and glycobiology, TB immunopathogenesis, and carbohydrate chemistry here proposes to investigate how
simple (amino/thio)sugars or other charged groups strategically placed within the Mtb cell envelope landscape
affect not only the physiology of this microorganism (Aim 1), but also the course of pulmonary infection,
pathology and development of innate and adaptive immunity in infected C3HeB/FeJ mice (Aim 2), and the
interactions of Mtb with host macrophages and dendritic cells thereby promoting survival within the host (Aim
3). Ultimately, these studies are expected to lead to significant new knowledge about the biological significance
of understudied aspects of the unique cell wall of mycobacteria.
抽象的
核细胞包膜聚糖的共价修饰,即脂多糖(LPS)和
(Lipo)Teichoic Acid,糖,氨基酸,磷酸盐或酰基等离散取代基是一种
革兰氏阴性和革兰氏阳性细菌使用的众所周知的策略来调节其细胞表面
财产,与环境互动的方式,对杀害剂和宿主防御的抵抗以及
致病性。尽管存在有证据表明结核分枝杆菌(MTB)类似地装饰了其专业
细胞包膜,阿拉伯分氏菌(Ag)和脂肪芳族瘤(LAM),带有各种剪裁取代基,
知之甚少,它们的生物学意义。我们的实验室发现生物合成机器的发现
负责将这些离散基序的合成和转移到Ag和Lam,以及生成
第一个MTB敲除突变体在其生物合成中缺乏
了解这些基序在MTB的生理学和免疫病变中的功能。我们
假设MTB已进化以修改其细胞 - 内玻璃糖,以不同的阵列
策略性地放置取代基,以促进其在宿主环境中的生存。因此,
多学科研究人员的多学科团队具有分枝杆菌细胞信封遗传学的互补专业知识
这里的糖生物学,结核病免疫发病发生和碳水化合物化学提议研究如何研究
简单的(氨基/硫糖)糖或其他充电基团在MTB细胞包膜景观中策略性地放置
不仅影响这种微生物的生理学(AIM 1),还影响肺部感染的过程,
感染的C3HEB/FEJ小鼠的病理和生育和适应性免疫的病理和自适应免疫(AIM 2)和
MTB与宿主巨噬细胞和树突状细胞的相互作用,从而促进宿主的生存(AIM
3)。最终,这些研究有望导致有关生物学意义的重大新知识
分枝杆菌独特细胞壁的研究不足。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mercedes Gonzalez-Juarrero其他文献
Mercedes Gonzalez-Juarrero的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mercedes Gonzalez-Juarrero', 18)}}的其他基金
Inhaled tigecycline therapy for pulmonary M. abscessus infections
吸入替加环素治疗肺部脓肿分枝杆菌感染
- 批准号:
10312329 - 财政年份:2021
- 资助金额:
$ 63.76万 - 项目类别:
Inhaled tigecycline therapy for pulmonary M. abscessus infections
吸入替加环素治疗肺部脓肿分枝杆菌感染
- 批准号:
10437923 - 财政年份:2021
- 资助金额:
$ 63.76万 - 项目类别:
Tailoring modifications of polysaccharides in Mycobacterium tuberculosis
结核分枝杆菌多糖的剪裁修饰
- 批准号:
10490882 - 财政年份:2021
- 资助金额:
$ 63.76万 - 项目类别:
Tailoring modifications of polysaccharides in Mycobacterium tuberculosis
结核分枝杆菌多糖的剪裁修饰
- 批准号:
10387219 - 财政年份:2021
- 资助金额:
$ 63.76万 - 项目类别:
Inhaled tigecycline therapy for pulmonary M. abscessus infections
吸入替加环素治疗肺部脓肿分枝杆菌感染
- 批准号:
10626051 - 财政年份:2021
- 资助金额:
$ 63.76万 - 项目类别:
Vectra Polaris microscope imaging system
Vectra Polaris 显微镜成像系统
- 批准号:
10175807 - 财政年份:2021
- 资助金额:
$ 63.76万 - 项目类别:
Minipigs as animal model for infant TB and vaccine efficacy
小型猪作为婴儿结核病和疫苗功效的动物模型
- 批准号:
8810222 - 财政年份:2014
- 资助金额:
$ 63.76万 - 项目类别:
siRNA-nanoparticles host targeted immunotherapy for tuberculosis
siRNA 纳米颗粒作为结核病靶向免疫疗法的宿主
- 批准号:
8638299 - 财政年份:2014
- 资助金额:
$ 63.76万 - 项目类别:
Minipigs as animal model for infant TB and vaccine efficacy
小型猪作为婴儿结核病和疫苗功效的动物模型
- 批准号:
8684285 - 财政年份:2014
- 资助金额:
$ 63.76万 - 项目类别:
相似国自然基金
低蛋白日粮脂肪和蛋白质互作影响氨基酸消化率的机制
- 批准号:32302793
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
关键非催化氨基酸残基影响新型GH43家族双功能酶底物特异性的机制研究
- 批准号:32301052
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
孕期母体支链氨基酸代谢紊乱和子代支链氨基酸代谢酶基因遗传变异联合作用对儿童神经行为发育影响的队列研究
- 批准号:82373581
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
影响植物磷砷选择性吸收关键氨基酸位点的挖掘及分子机制研究
- 批准号:42307009
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
RET基因634位点不同氨基酸改变对甲状腺C细胞的影响与机制研究
- 批准号:82370790
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
相似海外基金
Development and Production of Standardized Reference Diets for Zebrafish Research
斑马鱼研究标准化参考饲料的开发和生产
- 批准号:
10823702 - 财政年份:2023
- 资助金额:
$ 63.76万 - 项目类别:
Tailoring modifications of polysaccharides in Mycobacterium tuberculosis
结核分枝杆菌多糖的剪裁修饰
- 批准号:
10490882 - 财政年份:2021
- 资助金额:
$ 63.76万 - 项目类别:
Tailoring modifications of polysaccharides in Mycobacterium tuberculosis
结核分枝杆菌多糖的剪裁修饰
- 批准号:
10387219 - 财政年份:2021
- 资助金额:
$ 63.76万 - 项目类别:
Safer and more effective FIX therapeutics: impact of codon optimization
更安全、更有效的 FIX 疗法:密码子优化的影响
- 批准号:
10372111 - 财政年份:2020
- 资助金额:
$ 63.76万 - 项目类别: